Related Experiment Videos
[Total synthesis of oxa-9-anthracyclines]
Chemical & Pharmaceutical Bulletin
|December 1, 1989
Summary
Synthesized novel anthracyclines from quinizarin and chiral precursors. The resulting glycosides showed no significant cytotoxic activity against L 1210 cells at 1 microgram/ml.
Area of Science:
- Organic Synthesis
- Medicinal Chemistry
- Glycoscience
Context:
- Anthracyclines are a class of compounds with significant clinical applications, primarily as anticancer agents.
- The development of novel anthracycline analogs is crucial for overcoming drug resistance and improving therapeutic efficacy.
- Synthetic strategies for accessing complex anthracycline structures are of great interest in drug discovery.
Purpose:
- To synthesize novel racemic and chiral 9-oxa-anthracyclinone derivatives.
- To explore glycosylation strategies using modified L-fucose and L-hexose sugars.
- To evaluate the cytotoxic activity of the synthesized anthracycline glycosides against L 1210 leukemia cells.
Summary:
- Racemic 7-hydroxy-9-oxa-anthracyclinone was synthesized in seven steps from quinizarin and resolved after glycosylation.
- Chiral pool syntheses yielded (8S)-8-hydroxymethyl-9-oxa-anthracyclinone and its 10-methylated derivatives.
- Glycosylation with modified sugars produced novel anthracyclines, which were tested for biological activity.
Impact:
- The study presents a synthetic route to novel anthracycline analogs with potential for further derivatization.
- The lack of significant cytotoxicity at tested concentrations provides a baseline for future structure-activity relationship studies.
- This research contributes to the understanding of structure-activity relationships in anthracycline-based compounds.